Beyond The Printed Page

  1. Making A Difference Matters
    12/17/2018

    Dr. Helen Torley, president and CEO of Halozyme Therapeutics, shares a story of how the biopharmaceutical industry makes a difference.

  2. Helen Torley’s Path To The C-Suite
    12/12/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her path to the c-suite, including the formative experience that best prepared her for becoming a CEO.

  3. Could Halozyme’s U.S. Patent 8,846,034 Be Another Royalty Boon?
    12/10/2018

    Helen Torley, president and CEO of Halozyme Therapeutics, discusses hyaluronan and the role it plays in development of ENHANZE, PEGPH20 along with a staining diagnostic to determine patients with high levels of hyaluronic acid (HA).

  4. Insight For First-Time CEOs Presenting At JPM
    12/4/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her approach to preparing and presenting as a first-time CEO at the annual J.P. Morgan Healthcare Conference.

  5. Tech, Tax Cuts, Trump, & More — A Diversity Of Biopharma Perspectives For 2019
    11/26/2018

    Seven biopharmaceutical industry thought leaders weigh in on technology, tax cuts, and the political landscape to help you get ready for the coming year.

  6. 6 Biopharma Executives On Breakthroughs For 2019
    11/19/2018

    Six biopharmaceutical executives share their thoughts on therapeutic categories where they’d like to see breakthroughs in 2019 and beyond.

  7. What Can Be Done To Save Biopharma’s Broken Image?
    11/14/2018

    Rob Wright shares a personal anecdote about his experience of breaking into the biopharmaceutical industry, along with insight from three biopharma CEOs on what can be done to save the industry’s

  8. Are You Paying It Forward As A Leader?
    10/22/2018

    Liz Barrett, CEO of Novartis Oncology, discusses taking a proactive approach toward mentoring tomorrow’s leaders.

  9. Novartis Oncology CEO Liz Barrett On Balancing Career And Family
    10/16/2018

    Novartis Oncology CEO, Liz Barrett, on career advancement and family, a common challenge for women in the workplace.

  10. Challenges Of Transformation And Balancing An Internal And External Network From BMS’s Lou Schmukler
    9/24/2018

    Lou Schmukler, president of global product development and supply at Bristol-Myers Squibb, provides a preview as to his approach to transformation the company’s product development and manufacturing operations, along with insight into the world of biopharmaceutical outsourcing.